1. 2 , , , ( , ).
2. , , 1 ( 1, 3, 6 12 ).
10.5. :
5 ( ) .
1. ( )
2. ( , );
3. ( , , , 5 );
4. ;
5. , <92%;
6. ( II-IV);
7. 2 ;
8. ;
9. .
11. :
11.1. :
1. .
2. , , , , , .
11.2. : ( ) , (, , > 70 ), .
11.3. :
, :
- .
- : 48 .
- + 48-72 .
:
:
| -- 28 | /: > 7 : <2 : 50 100 12 . ≥ 2 : 75 150 8 ≥ 7 : <1,2 : 50 100 , 12 . : 1,2 2 : 75 150 8 . > 2 : 100 200 6 /: ≤ 7 : 100 12 : > 7 : 150 8 : , . | , / /, . ( ) | |
| 4 3 | . 90 8 7 , 10 1, 5 2- 5 | 50 3 / (A)(8) macrolides(8) (C).10 // 1 , 5 // 2- 5 /. 100 \ 8 100 \ 8 , / ( ) 200-300 // 4-6 ( 30 ) | 2-3 100 \ 8 () (12) 10 // 1 , 5 // 2- 5 /. 100 \ 8 10 // 1 , 5 // 2- 5 /. () (13) 50-75// 1-2 / /. 40-80 // 2-4 |
| 4 5 | ( ) 90 8 7 ( ) 10 1, 5 2- 5 , 20-40 // 2-3 . ( ) | 10 // 1 , 5 // 2- 5 /. 100 \ 6 100 \ 8 : / 50 // 3 /. | 100 \ 8 10 // 1 , 5 // 2- 5 /. 100 \ 8 10 // 1 , 5 // 2- 5 /. 15-25 // 6 , . 40-80 // 2-4 |
| 5 | 10 ( 500 ) 1 , 5 2 5 15 12 7 10 90 8 . ( ) | 200 \ 8 100 \ 6 100 \ 8 : 50 // 3 /. / 200-300 // 4-6 ( 30 ). 10 // 1 , 5 // 2- 5 /. / 200-300 // 4-6 ( 30 ). | 100 \ 8 10 // 1 , 5 // 2- 5 /. 100 \ 8 10 // 1 , 5 // 2- 5 /. (B) (10) 15-25 // 6 , . (D)40-80 // 2-4 |
|
|
|
|
|
|
1. 48-72 ( 3- )
2. , , .
3. , , , ( A).
4. !
5. ( )
:
- , , (, , ).
- , , .
- , , - .
- : ( ) --2b, , .
- (8 / 40 / / 8 3 ) 3 .
- : 5 \\ 14 , (0.5 // 1 / 10-14 )
12. :
1. 200 , 500 .; 2,4% ; 80 ;
2. , 510 / 34
3. 125 , 500 .; 250 ; 200 /100 ;
4. 5. 150 000 /;
6. 250 , .; 250-500 , ; 500 -1000 ; 125/5 ;
7. 500-1000 , .; 250-500 , ; 250 /5 , ;
8. + , 500 /125 , 875 /125 , 500/100;
9. 100 / ; 2 , 4 .; 20 ;
10. 250 , 500 , 1000 ;
11. 250-500 , ., 125 , 250 /5 ;
12. 250 , 500 .; 750 , ;
13. 100 , 250 500 .15-20 // 1-2
14. . 5/
15. . 30, 45, 75 . 30 /1.
16. ( ) --2b 150 ., 500.,
:
1. 500 , .;
2. 5 /;
3. 200, 800 , .;
4. + 480 /5 , .; 120 , 480 , .;
|
|
|
480 /5, ; 500 , .;
5. 150 - 10 \.
6. 50 , 150 .
7. 50 ;
8. 500 , .;
9. 125, 250, 500 1
10. :
1 2 40 80 ;
10 .
11. 0,5% - / . 100 0,5% - . - .
13. :
1.
2.
3.
4.
5.
6. .
14. :
1. Guidelines for Preventing Health-Care-Associated Pneumonia, 2003, Recommendations of CDC and the Healthcare Infection, Control Practices Advisory Committee, Morbidity and Mortality Weekly Report Recommendations and Reports March 26, 2004 / Vol. 53 / No. RR-3
2. Evidence Based Clinical Practice Guideline For Infection Prophylaxis - PCP Guideline 15, Health Policy & Clinical Effectiveness, Evidence Based Clinical Practice Guideline, Pneumocystis Carinii Pneumonia Prophylaxis following Solid Organ or Blood & Marrow Transplants Publication Date: 01-12-01
3. Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children under two years of age, Evidence Summaries, 17.1.2005
4. Pneumonia, EBM Guidelines, 11.6.2004
5. Treatment of pneumonia in children, EBM Guidelines, 03.05.2000
6. . . , , 2003
7. . . 3. , , 2004.
8. , : ./ . .. , .. , .. , .. .- 2- ., . - .: -, 2003. - 1248.
9. Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age.
| 10. Cincinnati Children's Hospital Medical Center. Evidence based care guideline for community acquired pneumonia in children 60 days through 17 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Jul. 16 p. [80 references] |
11. Int J Antimicrob Agents. 2005 Jun;25(6):514-22 pubmed
12. http://www.ncbi.nlm.nih.gov/pubmed/10590282
13. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004874.pub3/abstract
14. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001954.pub3/abstract
15. http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/DARE-12010006382/frame.html
4 : , , D.
| A | . , | |
| B | ||
| C | , , , | |
| D | ; |
|
|
|
16. :
.., ..., .
.., ..., , . 3
